Bordetella pertussis remains in fifth place in the list of deaths attributed to vaccine-
preventable diseases in children under 5 years of age around the world. It causes significant …

BACKGROUND:: Lifetime protection against pertussis has been adopted as a goal of
immunization programs in Canada. To anticipate adult coverage with a combined product …

We evaluated pertussis-specific cell-mediated immunity (CMI) and humoral immunity in
adolescents 3 years after they received an acellular pertussis booster immunization. Two …

Abstract In North America, children currently receive 5 doses of a combined diphtheria-
tetanus-acellular pertussis vaccine between the ages of 2 months and 6 years. Although this …

Background: During the decade 1998-2007, a combination DTaP 5-IPV/Hib vaccine was
used exclusively in Canada to immunize infants and young children against diphtheria …

Introduction: Pertussis is a highly communicable, vaccine-preventable respiratory disease
and a frequent but often underestimated cause of prolonged cough illness in adults …

Atualmente, a coqueluche representa um crescente problema de saúde pública em países
desenvolvidos. Nesses países, a imunização em massa de crianças, iniciada na década de …

Objectives In Latin America and the Caribbean (LAC), pertussis disease incidence has
reportedly increased since 2000 despite high vaccine coverage. A systematic review of …

Military training facilities and operational theatres, and the stressful activities undertaken in
such settings, are unique. Military personnel living and working in these environments are at …

The annual contact for influenza vaccination provides an opportunity to ensure that adults
have received other recommended vaccines such as Tdap. Healthy 19–64 year-olds were …